AU2009215361A1 - Method of nucleic acid recombination - Google Patents
Method of nucleic acid recombination Download PDFInfo
- Publication number
- AU2009215361A1 AU2009215361A1 AU2009215361A AU2009215361A AU2009215361A1 AU 2009215361 A1 AU2009215361 A1 AU 2009215361A1 AU 2009215361 A AU2009215361 A AU 2009215361A AU 2009215361 A AU2009215361 A AU 2009215361A AU 2009215361 A1 AU2009215361 A1 AU 2009215361A1
- Authority
- AU
- Australia
- Prior art keywords
- nucleic acid
- single stranded
- replacement
- region
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims description 597
- 102000039446 nucleic acids Human genes 0.000 title claims description 593
- 108020004707 nucleic acids Proteins 0.000 title claims description 593
- 238000005215 recombination Methods 0.000 title claims description 290
- 230000006798 recombination Effects 0.000 title claims description 289
- 238000000034 method Methods 0.000 title claims description 147
- 108020004414 DNA Proteins 0.000 claims description 208
- 239000000758 substrate Substances 0.000 claims description 179
- 102000053602 DNA Human genes 0.000 claims description 152
- 101100316841 Escherichia phage lambda bet gene Proteins 0.000 claims description 137
- 125000003729 nucleotide group Chemical group 0.000 claims description 110
- 239000002773 nucleotide Substances 0.000 claims description 107
- 108090000623 proteins and genes Proteins 0.000 claims description 97
- 108091034117 Oligonucleotide Proteins 0.000 claims description 95
- 101100226347 Escherichia phage lambda exo gene Proteins 0.000 claims description 77
- 108060002716 Exonuclease Proteins 0.000 claims description 70
- 102000013165 exonuclease Human genes 0.000 claims description 70
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 64
- 230000035772 mutation Effects 0.000 claims description 64
- 238000002744 homologous recombination Methods 0.000 claims description 49
- 230000006801 homologous recombination Effects 0.000 claims description 49
- 230000000295 complement effect Effects 0.000 claims description 42
- 102000004169 proteins and genes Human genes 0.000 claims description 41
- 230000000694 effects Effects 0.000 claims description 40
- 230000004048 modification Effects 0.000 claims description 35
- 238000012986 modification Methods 0.000 claims description 35
- 238000000137 annealing Methods 0.000 claims description 32
- 230000037431 insertion Effects 0.000 claims description 31
- 238000003780 insertion Methods 0.000 claims description 31
- 108060004795 Methyltransferase Proteins 0.000 claims description 26
- 241000588724 Escherichia coli Species 0.000 claims description 25
- 238000006467 substitution reaction Methods 0.000 claims description 21
- 230000015556 catabolic process Effects 0.000 claims description 19
- 238000006731 degradation reaction Methods 0.000 claims description 19
- 230000037430 deletion Effects 0.000 claims description 17
- 238000012217 deletion Methods 0.000 claims description 17
- 239000003550 marker Substances 0.000 claims description 16
- 125000005642 phosphothioate group Chemical group 0.000 claims description 15
- 230000008439 repair process Effects 0.000 claims description 14
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 13
- 230000003115 biocidal effect Effects 0.000 claims description 13
- 238000000926 separation method Methods 0.000 claims description 13
- 101150072534 sbcB gene Proteins 0.000 claims description 11
- 102000001218 Rec A Recombinases Human genes 0.000 claims description 9
- 108010055016 Rec A Recombinases Proteins 0.000 claims description 9
- 230000027455 binding Effects 0.000 claims description 9
- 150000001413 amino acids Chemical class 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 229960002685 biotin Drugs 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- 125000001921 locked nucleotide group Chemical group 0.000 claims description 3
- MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical class C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 claims description 2
- 241000206602 Eukaryota Species 0.000 claims description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical class O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 69
- 239000000543 intermediate Substances 0.000 description 40
- 235000018102 proteins Nutrition 0.000 description 39
- 230000001404 mediated effect Effects 0.000 description 32
- 239000013612 plasmid Substances 0.000 description 31
- 230000010076 replication Effects 0.000 description 29
- 238000006243 chemical reaction Methods 0.000 description 26
- 239000012634 fragment Substances 0.000 description 26
- 238000003556 assay Methods 0.000 description 25
- 230000037361 pathway Effects 0.000 description 23
- 238000002474 experimental method Methods 0.000 description 22
- 230000015572 biosynthetic process Effects 0.000 description 16
- 210000000349 chromosome Anatomy 0.000 description 15
- 230000007246 mechanism Effects 0.000 description 15
- 101000938776 Homo sapiens ETS domain-containing transcription factor ERF Proteins 0.000 description 13
- 238000004520 electroporation Methods 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 238000002741 site-directed mutagenesis Methods 0.000 description 13
- 230000008901 benefit Effects 0.000 description 12
- 230000012361 double-strand break repair Effects 0.000 description 12
- 238000003786 synthesis reaction Methods 0.000 description 12
- 230000014509 gene expression Effects 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 238000000338 in vitro Methods 0.000 description 10
- 230000033607 mismatch repair Effects 0.000 description 10
- 238000012360 testing method Methods 0.000 description 9
- 230000009466 transformation Effects 0.000 description 9
- 229930027917 kanamycin Natural products 0.000 description 8
- 229960000318 kanamycin Drugs 0.000 description 8
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 8
- 229930182823 kanamycin A Natural products 0.000 description 8
- 238000002703 mutagenesis Methods 0.000 description 8
- 231100000350 mutagenesis Toxicity 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 7
- 210000004436 artificial bacterial chromosome Anatomy 0.000 description 7
- 230000005782 double-strand break Effects 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 7
- 230000003362 replicative effect Effects 0.000 description 7
- 239000013598 vector Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 108091027305 Heteroduplex Proteins 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 6
- 229960000723 ampicillin Drugs 0.000 description 6
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 6
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 6
- 230000004186 co-expression Effects 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 235000021317 phosphate Nutrition 0.000 description 6
- 108091008146 restriction endonucleases Proteins 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 108020004682 Single-Stranded DNA Proteins 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 229960005091 chloramphenicol Drugs 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 230000004543 DNA replication Effects 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 4
- 229930189065 blasticidin Natural products 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000012552 review Methods 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 230000006269 (delayed) early viral mRNA transcription Effects 0.000 description 3
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000003527 eukaryotic cell Anatomy 0.000 description 3
- 238000010363 gene targeting Methods 0.000 description 3
- 238000012248 genetic selection Methods 0.000 description 3
- 229930195712 glutamate Natural products 0.000 description 3
- 230000014725 late viral mRNA transcription Effects 0.000 description 3
- 101150003248 malK gene Proteins 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 108010068698 spleen exonuclease Proteins 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 2
- 241000701959 Escherichia virus Lambda Species 0.000 description 2
- 108091092566 Extrachromosomal DNA Proteins 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- -1 RecT Proteins 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 108020005091 Replication Origin Proteins 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 108010052160 Site-specific recombinase Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000007806 chemical reaction intermediate Substances 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000009699 differential effect Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 210000001671 embryonic stem cell Anatomy 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 238000010362 genome editing Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000012872 hydroxylapatite chromatography Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 108700010839 phage proteins Proteins 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 101150098466 rpsL gene Proteins 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- WIKQLQXZUYAZQC-WYWOCYEQSA-N (2s,5r)-3,3-dimethyl-4,4,7-trioxo-4$l^{6}-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(6r,7r)-7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[ Chemical compound O=S1(=O)C(C)(C)[C@H](C(O)=O)N2C(=O)C[C@H]21.O=C1C(=O)N(CC)CCN1C(=O)NC(C=1C=CC(O)=CC=1)C(=O)N[C@@H]1C(=O)N2C(C(O)=O)=C(CSC=3N(N=NN=3)C)CS[C@@H]21 WIKQLQXZUYAZQC-WYWOCYEQSA-N 0.000 description 1
- 101150072531 10 gene Proteins 0.000 description 1
- 101150098072 20 gene Proteins 0.000 description 1
- 108010011170 Ala-Trp-Arg-His-Pro-Gln-Phe-Gly-Gly Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 101100455969 Bacillus subtilis (strain 168) mdxK gene Proteins 0.000 description 1
- 101000740587 Botryotinia fuckeliana Presilphiperfolan-8-beta-ol synthase Proteins 0.000 description 1
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 241001137903 Centropomus pectinatus Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 101150026402 DBP gene Proteins 0.000 description 1
- 238000012270 DNA recombination Methods 0.000 description 1
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
- 101710116602 DNA-Binding protein G5P Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000175212 Herpesvirales Species 0.000 description 1
- 108010025076 Holoenzymes Proteins 0.000 description 1
- 101000938790 Homo sapiens Eukaryotic peptide chain release factor subunit 1 Proteins 0.000 description 1
- 101000581802 Homo sapiens Lithostathine-1-alpha Proteins 0.000 description 1
- 101000713585 Homo sapiens Tubulin beta-4A chain Proteins 0.000 description 1
- 241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
- 108010015268 Integration Host Factors Proteins 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 102100027361 Lithostathine-1-alpha Human genes 0.000 description 1
- 101100446513 Mus musculus Fgf4 gene Proteins 0.000 description 1
- 101150012532 NANOG gene Proteins 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 101100355599 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) mus-11 gene Proteins 0.000 description 1
- RZMHECYBKLOMKN-UHFFFAOYSA-N OC(=O)CP(=O)=O Chemical class OC(=O)CP(=O)=O RZMHECYBKLOMKN-UHFFFAOYSA-N 0.000 description 1
- 238000009004 PCR Kit Methods 0.000 description 1
- 108010010677 Phosphodiesterase I Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 102100038276 Protein Red Human genes 0.000 description 1
- 101710150120 Protein Red Proteins 0.000 description 1
- 101710130181 Protochlorophyllide reductase A, chloroplastic Proteins 0.000 description 1
- 101150006234 RAD52 gene Proteins 0.000 description 1
- 102000053062 Rad52 DNA Repair and Recombination Human genes 0.000 description 1
- 108700031762 Rad52 DNA Repair and Recombination Proteins 0.000 description 1
- 102000019196 RecQ Helicases Human genes 0.000 description 1
- 108010012737 RecQ Helicases Proteins 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 101710162453 Replication factor A Proteins 0.000 description 1
- 101710176758 Replication protein A 70 kDa DNA-binding subunit Proteins 0.000 description 1
- 101710176276 SSB protein Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 101710126859 Single-stranded DNA-binding protein Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 102100036788 Tubulin beta-4A chain Human genes 0.000 description 1
- 101150023763 UL12 gene Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 101000617544 Xenopus laevis Presenilin-2 Proteins 0.000 description 1
- CQAYJDMWUGRKOJ-UHFFFAOYSA-N acetyloxy-oxido-oxophosphanium Chemical compound CC(=O)O[P+]([O-])=O CQAYJDMWUGRKOJ-UHFFFAOYSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000008519 endogenous mechanism Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 238000012226 gene silencing method Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 229930001119 polyketide Natural products 0.000 description 1
- 150000003881 polyketide derivatives Chemical class 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 108020001580 protein domains Proteins 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 101150079601 recA gene Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 108010004034 stable plasma protein solution Proteins 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- OIWCYIUQAVBPGV-DAQGAKHBSA-N {1-O-hexadecanoyl-2-O-[(Z)-octadec-9-enoyl]-sn-glycero-3-phospho}serine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC OIWCYIUQAVBPGV-DAQGAKHBSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0803109.8A GB0803109D0 (en) | 2008-02-20 | 2008-02-20 | Method of nucleic acid recombination |
| GB0803109.8 | 2008-02-20 | ||
| PCT/IB2009/000488 WO2009104094A2 (en) | 2008-02-20 | 2009-02-20 | Method of nucleic acid recombination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2009215361A1 true AU2009215361A1 (en) | 2009-08-27 |
Family
ID=39272012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2009215361A Abandoned AU2009215361A1 (en) | 2008-02-20 | 2009-02-20 | Method of nucleic acid recombination |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8728820B2 (https=) |
| EP (1) | EP2255001B1 (https=) |
| JP (1) | JP5703031B2 (https=) |
| CN (1) | CN102027112B (https=) |
| AU (1) | AU2009215361A1 (https=) |
| CA (1) | CA2715871A1 (https=) |
| GB (1) | GB0803109D0 (https=) |
| WO (1) | WO2009104094A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011058555A1 (en) * | 2009-11-12 | 2011-05-19 | Yeda Research And Development Co. Ltd. | A method of editing dna in a cell and constructs capable of same |
| GB201009732D0 (en) | 2010-06-10 | 2010-07-21 | Gene Bridges Gmbh | Direct cloning |
| US12595500B2 (en) | 2011-09-26 | 2026-04-07 | Life Technologies Corporation | High efficiency, small volume nucleic acid synthesis |
| CN103945931B (zh) | 2011-09-26 | 2017-03-22 | 基因技术股份公司 | 高效的小体积核酸合成 |
| WO2014153188A2 (en) * | 2013-03-14 | 2014-09-25 | Life Technologies Corporation | High efficiency, small volume nucleic acid synthesis |
| US10407676B2 (en) | 2014-12-09 | 2019-09-10 | Life Technologies Corporation | High efficiency, small volume nucleic acid synthesis |
| KR102530821B1 (ko) | 2014-12-19 | 2023-05-10 | 리제너론 파마슈티칼스 인코포레이티드 | 단일 단계 다중 표적화를 통한 표적화된 유전자 변형을 위한 방법 및 조성물 |
| WO2016196887A1 (en) * | 2015-06-03 | 2016-12-08 | Board Of Regents Of The University Of Nebraska | Dna editing using single-stranded dna |
| CN106011162A (zh) * | 2016-01-27 | 2016-10-12 | 浙江大学 | 大肠杆菌细胞内原位进化目标蛋白质的新方法 |
| US11866724B2 (en) | 2016-04-06 | 2024-01-09 | Gene Bridges Gmbh | Adenoviral vectors |
| JP6899564B2 (ja) * | 2016-08-12 | 2021-07-07 | Ｎｅｘｕｓｐｉｒａｌ株式会社 | ゲノム編集方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5518900A (en) * | 1993-01-15 | 1996-05-21 | Molecular Tool, Inc. | Method for generating single-stranded DNA molecules |
| AU752105B2 (en) * | 1997-12-05 | 2002-09-05 | Europaisches Laboratorium Fur Molekularbiologie (Embl) | Novel dna cloning method |
| US6355412B1 (en) * | 1999-07-09 | 2002-03-12 | The European Molecular Biology Laboratory | Methods and compositions for directed cloning and subcloning using homologous recombination |
| WO2002014495A2 (en) * | 2000-08-14 | 2002-02-21 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Enhanced homologous recombination mediated by lambda recombination proteins |
| US20040029129A1 (en) * | 2001-10-25 | 2004-02-12 | Liangsu Wang | Identification of essential genes in microorganisms |
-
2008
- 2008-02-20 GB GBGB0803109.8A patent/GB0803109D0/en not_active Ceased
-
2009
- 2009-02-20 CA CA2715871A patent/CA2715871A1/en not_active Abandoned
- 2009-02-20 JP JP2010547269A patent/JP5703031B2/ja not_active Expired - Fee Related
- 2009-02-20 EP EP09711877.2A patent/EP2255001B1/en not_active Not-in-force
- 2009-02-20 US US12/918,134 patent/US8728820B2/en not_active Expired - Fee Related
- 2009-02-20 CN CN2009801137719A patent/CN102027112B/zh not_active Expired - Fee Related
- 2009-02-20 WO PCT/IB2009/000488 patent/WO2009104094A2/en not_active Ceased
- 2009-02-20 AU AU2009215361A patent/AU2009215361A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009104094A3 (en) | 2009-12-17 |
| WO2009104094A2 (en) | 2009-08-27 |
| JP5703031B2 (ja) | 2015-04-15 |
| EP2255001B1 (en) | 2015-03-25 |
| CA2715871A1 (en) | 2009-08-27 |
| JP2011512153A (ja) | 2011-04-21 |
| GB0803109D0 (en) | 2008-03-26 |
| CN102027112A (zh) | 2011-04-20 |
| US20110165630A1 (en) | 2011-07-07 |
| US8728820B2 (en) | 2014-05-20 |
| CN102027112B (zh) | 2013-11-06 |
| EP2255001A2 (en) | 2010-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2255001B1 (en) | Method of nucleic acid recombination | |
| US12195732B2 (en) | Direct cloning | |
| Thomason et al. | Gene insertion and replacement in Schizosaccharomyces pombe mediated by the Streptomyces bacteriophage φC31 site-specific recombination system | |
| KR102488128B1 (ko) | 게놈의 큰 단편 직접 클로닝 및 dna 다중-분자 어셈블리를 위한 새로운 기술 | |
| AU1877199A (en) | Novel dna cloning method | |
| CN112301024A (zh) | 使用RNA引导的FokI核酸酶(RFN)提高RNA引导的基因组编辑的特异性 | |
| WO2024081738A2 (en) | Compositions, methods, and systems for dna modification | |
| US7592161B2 (en) | Methods for analyzing the insertion capabilities of modified group II introns | |
| JP2004518419A (ja) | 基質連結型指向性進化（ＳＬｉＤＥ） | |
| CA2436743A1 (en) | Recombination method | |
| US7323313B2 (en) | Methods for protein interaction determination | |
| WO2010113031A2 (en) | Method of altering nucleic acids | |
| WO2010140066A2 (en) | Method of altering nucleic acids | |
| EP1838851B1 (en) | Polypeptide mutagenesis method | |
| EP1546395A2 (en) | Methods and nucleic acid vectors for rapid expression and screening of cdna clones | |
| AU2002253479A1 (en) | Recombination method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |